Skip to main content

Table 1 Interventions within Network Diagram

From: Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis

NO Drug Abbreviation Patients
1 I.V Hydration I.V 5136
2 Statins Sta 3040
3 Furosemide Fur 554
4 NAC NAC 6095
5 Trimetazidine Tri 352
6 NaHCO3 NaH 3393
7 PGE1 PGE 304
8 MgSO4 MgS 62
9 Pentoxifylline Pen 438
10 Placebo Pla 7044
11 Control Con 9120
12 Allopurinol All 204
13 BNP BNP 744
14 Probucol Pro 198
15 α-tocopherol α-t 312
16 γ-tocopherol γ-t 102
17 Oxygen Oxy 346
18 Amlodipine and Valsartan Aml 45
19 K/Na citrate K/N 203
20 Nicorandil Nic 291
21 Ascorbic Acid Asc 552
22 Alpha-Lipoic Acid Alp 139
23 Oral Hydration Ora 254
24 Nebivolol Neb 40
25 Anisodamine Ani 192
26 RIPC RIP 608
27 Theophylline The 384
28 Hypothermia Hyp 58
29 Glutathione Glu 421
30 MESNA MES 51
31 ACEI AC 129
32 Aminophylline Ami 45
33 Iloprost Ilo 118
34 Acetazolamide Ace 94
35 ANP ANP 202
36 Zinc Zin 18
37 Dialysis Dia 293
38 Fenoldopam Fe 333
39 ERAs ER 77
40 CCB CC 42
41 Dopamine Do 48
42 Mannitol Ma 35
43 Cordyceps Co 88
44 Silymarin Si 69
  1. ACEI Angiotensin Converting-Enzyme Inhibitor, ANP Atrial Natriuretic Peptide, BNP B-Type Natriuretic Peptide, CCB Calcium Channels Blockers, CI-AKI Contrast Induced Acute Kidney Injury, CIN Contrast Induced Nephropathy, ERAs Endothelin Receptor Antagonism, MESNA 2-Mercaptoethane Sulfonate Sodium, MgSo4 Magnesium Sulphate, NAC N-acetyl cysteine, NaHco3 Sodium Bicarbonate, PGE1 Prostaglandin E1, RIPC Remote Ischemic Preconditioning